Pyoderma gangrenosum of the ocular adnexa: a rare condition with characteristic clinical appearances

Ophthalmology. 2003 Apr;110(4):801-5. doi: 10.1016/S0161-6420(02)01966-8.

Abstract

Purpose: To describe the clinical characteristics of periocular pyoderma gangrenosum and to highlight features that may encourage early diagnosis of this extremely rare condition.

Design: Retrospective, noncomparative, interventional case series.

Participants and methods: Four patients with periocular pyoderma gangrenosum were treated in the Orbital Unit at Moorfields Eye Hospital over the course of a decade.

Main outcome measures: Presenting clinical features, therapy, and outcome.

Results: Four patients (female) between the ages of 56 and 75 years (mean, 65 years; median, 64 years) sought treatment for slowly evolving, painful, unilateral blue-gray swellings of the pretarsal tissues of the lower (1 case), upper (1 case), or both eyelids (2 cases). The swelling progressed to frank tissue necrosis and loss of full-thickness eyelid, with patchy sparing of the lid margin or lashes; in some cases, there was a very distinctive preservation of the pretarsal marginal artery across full-thickness eyelid defects. The lid loss characteristically involved the lateral one third of the lower eyelid (3 of 4 lids), the central part of the upper eyelid (3 of 4 lids) and, in one case, extending into the postseptal tissues in the inferotemporal quadrant of the orbit. In 3 patients, the pyoderma, often associated with a positive serum rheumatoid factor (three of three cases where measured), responded well to systemic immunosuppression and eyelid repair was undertaken during the quiescent phase. In a single patient, relapsing disease led to loss of the eye as a result of involvement of the globe and deep orbital tissues.

Conclusions: Although an extremely rare condition, periocular pyoderma gangrenosum has a typical clinical appearance, and early recognition and immunosuppression will reduce the ocular morbidity.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Combined Modality Therapy
  • Cyclophosphamide / therapeutic use
  • Epithelial Cells / transplantation
  • Eyelid Diseases / diagnosis*
  • Eyelid Diseases / drug therapy
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Infusions, Intravenous
  • Male
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Plastic Surgery Procedures
  • Pyoderma Gangrenosum / diagnosis*
  • Pyoderma Gangrenosum / drug therapy
  • Retrospective Studies
  • Sclera / transplantation
  • Scleritis / diagnosis
  • Scleritis / drug therapy
  • Stem Cell Transplantation

Substances

  • Immunosuppressive Agents
  • Cyclophosphamide
  • Methylprednisolone